Both Semaglutide and copyright are a category of drugs called GLP-1 receptor stimulators. These innovative medicines function by mimicking the body's natural hormone , Glucagon-like Peptide-1, to assist reduce blood sugar and encourage weight reduction . This common mechanism of function explains

Sufferers struggling with obesity are often faced with limited and sometimes ineffective treatment options. However, a groundbreaking new medication, Semaglutide, is rapidly changing the landscape of weight loss. Approved by regulatory bodies for chronic weight management, Semaglutide functions